Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street.
Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street.
复制标题
DOI:
10.1016/j.molmet.2021.101261
复制
发表时间:
2021-10
影响因子:
8.1
通讯作者:
Newgard CB
中科院分区:
文献类型:
--
作者:
White PJ;McGarrah RW;Herman MA;Bain JR;Shah SH;Newgard CB
A strong association of obesity and insulin resistance with increased circulating levels of branched-chain and aromatic amino acids and decreased glycine levels has been recognized in human subjects for decades. More recently, human metabolomics and genetic studies have confirmed and expanded upon these observations, accompanied by a surge in preclinical studies that have identified mechanisms involved in the perturbation of amino acid homeostasis— how these events are connected to dysregulated glucose and lipid metabolism, and how elevations in branched-chain amino acids (BCAA) may participate in the development of insulin resistance, type 2 diabetes (T2D), and other cardiometabolic diseases and conditions. In human cohorts, BCAA and related metabolites are now well established as among the strongest biomarkers of obesity, insulin resistance, T2D, and cardiovascular diseases. Lowering of BCAA and branched-chain ketoacid (BCKA) levels by feeding BCAA-restricted diet or by the activation of the rate-limiting enzyme in BCAA catabolism, branched-chain ketoacid dehydrogenase (BCKDH), in rodent models of obesity have clear salutary effects on glucose and lipid homeostasis, but BCAA restriction has more modest effects in short-term studies in human T2D subjects. Feeding of rats with diets enriched in sucrose or fructose result in the induction of the ChREBP transcription factor in the liver to increase expression of the BCKDH kinase (BDK) and suppress the expression of its phosphatase (PPM1K) resulting in the inactivation of BCKDH and activation of the key lipogenic enzyme ATP-citrate lyase (ACLY). These and other emergent links between BCAA, glucose, and lipid metabolism motivate ongoing studies of possible causal actions of BCAA and related metabolites in the development of cardiometabolic diseases. Branched-chain amino acids (BCAA) are associated with metabolic disease phenotypes. Obesity-driven changes in BCAA metabolism affect lipid and glucose metabolism. BCAA and branched-chain ketoacids (BCKA) have direct effects on tissue functions. Activation of BCAA metabolism improves glucose and lipid homeostasis.
登录
查看更多内容
影响因子:
3.7
作者:
Macotela Y;Emanuelli B;Bång AM;Espinoza DO;Boucher J;Beebe K;Gall W;Kahn CR
通讯作者:
Kahn CR
影响因子:
37.8
作者:
Cheng S;Rhee EP;Larson MG;Lewis GD;McCabe EL;Shen D;Palma MJ;Roberts LD;Dejam A;Souza AL;Deik AA;Magnusson M;Fox CS;O'Donnell CJ;Vasan RS;Melander O;Clish CB;Gerszten RE;Wang TJ
通讯作者:
Wang TJ
DOI:
10.1152/ajpendo.00334.2019
发表时间:
2020-02-01
影响因子:
5.1
作者:
McGarrah, Robert W.;Zhang, Guo-Fang;Newgard, Christopher B.
通讯作者:
Newgard, Christopher B.
DOI:
10.1152/ajpendo.00630.2012
发表时间:
2013-06-01
影响因子:
5.1
作者:
Lackey, Denise E.;Lynch, Christopher J.;Adams, Sean H.
通讯作者:
Adams, Sean H.
影响因子:
8.2
作者:
Kadakia, Rachel;Nodzenski, Michael;Lowe, William L., Jr.
通讯作者:
Lowe, William L., Jr.